Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Trends in Immunology
|
July 14, 2023
MAdCAM-1: a newly identified microbial 'gut check' for T cells
Manoj Chelvanambi, Jennifer A Wargo
Med (New York, N.Y.)
|
May 18, 2022
Trust your gut when it comes to driving CARs
Manoj Chelvanambi, Jennifer A Wargo
Cell Reports. Medicine
|
January 14, 2022
More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer
Manoj Chelvanambi, Jennifer A Wargo
Trends in Immunology
|
April 10, 2022
Immunotherapy response-associated Akkermansia: canary in a coal mine?
Tina Cascone, Manoj Chelvanambi, Jennifer A Wargo
Advances in Experimental Medicine and Biology
|
February 16, 2020
IL-36 Signaling in the Tumor Microenvironment
Manoj Chelvanambi, Aliyah M Weinstein, Walter J Storkus
Cancers
|
February 11, 2023
Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
Anne Knisely, Yongwoo David Seo, Jennifer A Wargo, et al.
Frontiers in Immunology
|
March 22, 2021
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
Deepak Salem, Manoj Chelvanambi, Walter J Storkus, et al.
Journal for Immunotherapy of Cancer
|
February 2, 2021
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald J Fecek, Jennifer L Taylor, et al.
Cancers
|
June 2, 2021
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.
Frontiers in Immunology
|
May 31, 2021
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Jessica N Filderman, Mark Appleman, Manoj Chelvanambi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Trends in Immunology
|
July 14, 2023
MAdCAM-1: a newly identified microbial 'gut check' for T cells
Manoj Chelvanambi, Jennifer A Wargo
Med (New York, N.Y.)
|
May 18, 2022
Trust your gut when it comes to driving CARs
Manoj Chelvanambi, Jennifer A Wargo
Cell Reports. Medicine
|
January 14, 2022
More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancer
Manoj Chelvanambi, Jennifer A Wargo
Trends in Immunology
|
April 10, 2022
Immunotherapy response-associated Akkermansia: canary in a coal mine?
Tina Cascone, Manoj Chelvanambi, Jennifer A Wargo
Advances in Experimental Medicine and Biology
|
February 16, 2020
IL-36 Signaling in the Tumor Microenvironment
Manoj Chelvanambi, Aliyah M Weinstein, Walter J Storkus
Cancers
|
February 11, 2023
Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
Anne Knisely, Yongwoo David Seo, Jennifer A Wargo, et al.
Frontiers in Immunology
|
March 22, 2021
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
Deepak Salem, Manoj Chelvanambi, Walter J Storkus, et al.
Journal for Immunotherapy of Cancer
|
February 2, 2021
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald J Fecek, Jennifer L Taylor, et al.
Cancers
|
June 2, 2021
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.
Frontiers in Immunology
|
May 31, 2021
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Jessica N Filderman, Mark Appleman, Manoj Chelvanambi, et al.
Page
of 3